Cargando…
Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections
BACKGROUND: For more effective and safer usage of antibiotics, the dosing strategy should be individualized based on the patients’ characteristics, including race. The aim of this study was to investigate the population pharmacokinetic (PK) profiles of piperacillin and tazobactam in Korean patients...
Autores principales: | Kim, Yong Kyun, Jung, Jin Ah, Choi, Hyang-Ki, Bae, In-Gyu, Choi, Won Suk, Hur, Jian, Jin, Sung Joon, Kim, Shin-Woo, Kwon, Ki Tae, Lee, Sang-Rok, Shin, Jae-Gook, Kiem, Sungmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048002/ https://www.ncbi.nlm.nih.gov/pubmed/27659435 http://dx.doi.org/10.3947/ic.2016.48.3.209 |
Ejemplares similares
-
Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation
por: Kim, Yong Kyun, et al.
Publicado: (2022) -
Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
por: Yang, Jihyun, et al.
Publicado: (2023) -
612. Pharmacokinetics of Piperacillin-Tazobactam in Patients with Severe Infections
por: Rodríguez-Báez, Ana S, et al.
Publicado: (2022) -
Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996) -
Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin–Tazobactam in Obese Patients
por: Veillette, John J., et al.
Publicado: (2021)